Board leadership
HCA chairman
HCA's 2026 proxy statement records the current board role.
This is an independent informational site. It is not affiliated with, endorsed by, or authorized by the named individual or any related entity.
Healthcare governance source guide
SEC-filed and issuer-source context for Thomas F. Frist III's public corporate roles.
Public record
HCA Healthcare's 2026 proxy statement identifies Thomas F. Frist III as Chairman of HCA's Board of Directors, a director since 2006, and founder and managing principal of Frist Capital, LLC since 1998.
HCA's April 2026 Form 8-K reports the annual-meeting director election. Issuer filings are the controlling source for current board roles and date-stamped ownership disclosures.
This site does not provide healthcare or investment advice, repeat unsupported ownership or wealth claims, solicit transactions, or represent Frist, HCA Healthcare, Frist Capital, or the Frist family.
At a glance
Board leadership
HCA's 2026 proxy statement records the current board role.
Director history
The issuer proxy supplies the date and governance context.
Investment role
The same filing identifies his founder and managing-principal role.
Issuer-filed board, biography, and ownership context.
Annual-meeting election record.
Issuer filing index for current records.